Thu, November 10, 2011
Wed, November 9, 2011
Tue, November 8, 2011
Mon, November 7, 2011
[ Mon, Nov 07th 2011 ] - Market Wire
30 a.m. ET
Sun, November 6, 2011
Sat, November 5, 2011
Fri, November 4, 2011
Thu, November 3, 2011
Wed, November 2, 2011
Tue, November 1, 2011
Mon, October 31, 2011
Sat, October 29, 2011
Fri, October 28, 2011
Thu, October 27, 2011
Wed, October 26, 2011
Tue, October 25, 2011

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare Conference on November 9, 2011


//health-fitness.news-articles.net/content/2011/ .. se-healthcare-conference-on-november-9-2011.html
Published in Health and Fitness on Wednesday, November 2nd 2011 at 18:20 GMT by Market Wire   Print publication without navigation


Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare... -- SAN DIEGO, Nov. 2, 2011 /PRNewswire/ --

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Credit Suisse Healthcare Conference on November 9, 2011

[ ]

SAN DIEGO, Nov. 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, November 9, 2011 at 1:30pm Mountain Time (3:30pm Eastern Time) during the Credit Suisse Healthcare Conference at the Arizona Biltmore Hotel in Phoenix.

.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit [ www.cadencepharm.com ].

Contacts:

William R. LaRue


SVP & Chief Financial Officer


Cadence Pharmaceuticals, Inc.


858-436-1400



SOURCE Cadence Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cadencepharm.com ]


Publication Contributing Sources